Mayo Clinic's approach
Mayo Clinic has been studying the use of convalescent plasma for many years and has used the therapy for treating infectious diseases. Through clinical trials, researchers have collected data and developed lifesaving procedures.
Mayo Clinic joined with medical centers across the U.S. to collect plasma from people who have recovered from COVID-19 to be used for convalescent plasma therapy. Mayo Clinic coordinated this government-sponsored program.
A team of Mayo doctors in many areas, including infectious diseases, laboratory medicine and pathology, blood collection and testing (transfusion medicine), pharmacy, virus studies (virology), and cardiovascular diseases, works together to study potential treatments for COVID-19 such as convalescent plasma therapy.
Mayo Clinic researchers are studying the virus that causes COVID-19 and how it affects the immune system. They're also studying drugs and treatments for COVID-19, including convalescent plasma.
Researchers are also working on developing vaccines and diagnostic and antibody tests, and are working to inform medical centers about ways to prevent and control infections. Researchers are active in clinical trials for COVID-19 and other infectious diseases.
Aug. 29, 2020